novavax nuvaxovid - Search News

News

Novavax Soars

PharmExec · 16h

FDA Grants Full Approval to Novavax’s Nuvaxovid COVID-19 Vaccine

Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.

WebMD · 17h

FDA Approves Novavax COVID Vaccine With Restricted Use

The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from COVID can also get the shot.

Investopedia on MSN · 1d

Novavax Stock Soars on FDA Approval for New COVID-19 Vaccine

Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, Nuvaxovid, is designed for older adults and those between the ages of 12 and 64 who have underlying conditions that puts them at higher risk from the disease.

Novavax Shares Rise on FDA License Application Approval for Nuvaxovid

The biotechnology company said the FDA approved the biologics license application for Nuvaxovid to prevent Covid-19 in adults ages 65 and up and individuals ages 12 through 64 who have at least one ...

Schaeffer's Investment Research1d

Novavax Stock Soars on FDA Approval for COVID Vaccine

In the options pits, NVAX has already seen quadruple the overall options volume it typically sees in an entire session, with ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

Novavax Soars

Trending now